Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-05-12
1976-10-19
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3122
Patent
active
039871940
ABSTRACT:
Swine dysentery can be treated by the administration to swine suffering from the disease of an effective amount of octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cycl opentacycloocten-1(4H)-one,8-[ [2-(diethylamino)ethyl]thio]acetate or octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cycl opentacycloocten-1(4H)-one,8-[ [2-[4-(2-hydroxyethyl)-1-piperazinyl]ethyl]thio]acetate.
REFERENCES:
egger et al., -- Chem. Abst. vol. 79 (1973) p. 65901V.
Baughn Charles O.
Brown William E.
Linkenheimer Wayne H.
Barrack Donald J.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Rosen Sam
Smith Merle J.
LandOfFree
Use of pleuromutilin derivatives for the treatment of swine dyse does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pleuromutilin derivatives for the treatment of swine dyse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pleuromutilin derivatives for the treatment of swine dyse will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-103038